Skip to main content
Breakthrough Chemistry, Inc. (BKTH)
OTCMKTS · Delayed Price · Currency is USD
0.0745
-0.0030 (-3.87%)
At close: Nov 9, 2026

Breakthrough Chemistry Financials Overview

Millions USD. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2024FY 2023FY 2022
Period EndingSep '24 Mar '24 Mar '23 Mar '22
Revenue
0.020.020.010.02
Revenue Growth
38.74%36.86%-17.34%-
Gross Profit
000.010.01
Operating Income
-0.19-0.19-0.14-0.07
Net Income
-0.22-0.22-0.19-0.15
Earnings Per Share
-0.02-0.02-0.02-
EPS Growth
----

Cash & Debt
Chart
Fiscal Year
CurrentFY 2024FY 2023FY 2022
Period EndingSep '24 Mar '24 Mar '23 Mar '22
Cash & Investments
0000.02
Total Debt
0.370.330.310.28
Net Cash (Debt)
-0.36-0.33-0.31-0.26
Net Cash Growth
----
Net Cash Per Share
-0.04-0.03-0.04-

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2024FY 2023FY 2022
Period EndingSep '24 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-0.1-0.1-0.09-0.08
Free Cash Flow
-0.1-0.1-0.09-0.08
Free Cash Flow Growth
----

Margins
Chart
Fiscal Year
TTMFY 2024FY 2023FY 2022
Period EndingSep '24 Mar '24 Mar '23 Mar '22
Gross Margin
6.48%5.89%75.90%43.89%
Operating Margin
-1012.10%-980.70%-979.09%-415.80%
Pretax Margin
-1157.76%-1166.47%-1354.03%-905.77%
Profit Margin
-1157.76%-1166.47%-1354.03%-905.77%

Valuation
Chart
Fiscal Year
CurrentFY 2024FY 2023FY 2022
Period EndingNov '26 Mar '24 Mar '23 Mar '22
PS Ratio
37.8052.47136.69132.16